Suppr超能文献

中药复方化瘀强肾通痹汤通过增强CD63介导的脂肪间充质干细胞来源外泌体miR-125b-5p的释放来改善类风湿性关节炎。

Chinese herbal formula Huayu-Qiangshen-Tongbi decoction ameliorates rheumatoid arthritis through enhancing the release of exosomal miR-125b-5p derived from adipose-derived stem cells by CD63.

作者信息

Xiao-Dong Wu, You-Bang Liang, Yun-Bao Niu, Yi-Hong Yang, Wen-Zhi Huang, Mao-Jie Wang, Li-Yan Mei, Kai-Xin Gao, Run-Yue Huang, Xiu-Min Chen

机构信息

State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou, University of Chinese Medicine, (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China.

Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

出版信息

Biol Res. 2025 Jul 10;58(1):47. doi: 10.1186/s40659-025-00628-z.

Abstract

BACKGROUND

Rheumatoid arthritis (RA) is a chronic and multifactorial inflammatory disease inducing damages in joints and extra-articular organs. Our previous study has revealed that Huayu-Qiangshen-Tongbi decoction (HQT) ameliorates RA through upregulating microRNA (miRNA) miR-125b-5p to suppress inflammation in rheumatoid fibroblast-like synoviocytes (FLSs). However, the mechanism of HQT increasing miR-125b-5p level in FLSs remains unclear. It has been reported that exosomal miR-125b-5p derived from adipose-derived stem cells (ADSCs) could ameliorate various diseases, yet the effect of exosomal miR-125b-5p derived from ADSCs on FLSs in RA under HQT treatment is largely unknown. The aim is to investigate whether HQT upregulated miR-125b-5p in FLSs through modifying exosomal miR-125b-5p derived from ASCs.

METHODS

Here, HQT-containing serum was prepared, co-culture of human FLS MH7A cells with ADSCs was performed, gene knockdown in ADSCs was assessed by short hairpin RNA (shRNA), protein degradation was identified after cycloheximide (CHX) treatment and ADSC-derived exosomes were collected to incubate MH7A cells and inject into RA rat model.

RESULTS

HQT elevates lipopolysaccharide (LPS)-reduced miR-125b-5p level in FLSs by enhancing the secretion of exosomal miR-125b-5p derived from ADSCs. Besides, HQT attenuates inflammation of FLSs in RA by exosomal miR-125b-5p derived from ADSCs in vitro and in vivo. Mechanistically, HQT suppresses CD63 degradation in ADSCs to facilitate the release of exosomal miR-125b-5p derived from ADSCs.

CONCLUSION

In summary, these findings reveal the mechanism of HQT elevating miR-125b-5p expression in FLSs and provide novel therapeutic strategy for RA treatment.

摘要

背景

类风湿关节炎(RA)是一种慢性多因素炎症性疾病,可导致关节和关节外器官损伤。我们之前的研究表明,化瘀强肾通痹汤(HQT)通过上调微小RNA(miRNA)miR-125b-5p来减轻类风湿成纤维样滑膜细胞(FLS)中的炎症,从而改善RA。然而,HQT提高FLS中miR-125b-5p水平的机制仍不清楚。据报道,脂肪来源干细胞(ADSC)衍生的外泌体miR-125b-5p可改善多种疾病,但HQT治疗下ADSC衍生的外泌体miR-125b-5p对RA中FLS的影响在很大程度上尚不清楚。目的是研究HQT是否通过修饰ASC衍生的外泌体miR-125b-5p来上调FLS中的miR-125b-5p。

方法

在此,制备含HQT的血清,将人FLS MH7A细胞与ADSC进行共培养,通过短发夹RNA(shRNA)评估ADSC中的基因敲低,在放线菌酮(CHX)处理后鉴定蛋白质降解,并收集ADSC衍生的外泌体来孵育MH7A细胞并注射到RA大鼠模型中。

结果

HQT通过增强ADSC衍生的外泌体miR-125b-5p的分泌来提高脂多糖(LPS)降低的FLS中miR-125b-5p水平。此外,HQT在体外和体内通过ADSC衍生的外泌体miR-125b-5p减轻RA中FLS的炎症。机制上,HQT抑制ADSC中CD63的降解,以促进ADSC衍生的外泌体miR-125b-5p的释放。

结论

总之,这些发现揭示了HQT提高FLS中miR-125b-5p表达的机制,并为RA治疗提供了新的治疗策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验